Primary tabs
The list of publications is indicative and may not include all publications.
West Nile neuroinvasive disease. Report of four cases in Northern Greece, 2018..
J Med Virol. 92(8), 1322-1325.
(2020).
Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer's disease..
Clin Chem Lab Med. 57(12), 1875-1881.
(2019).
Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis..
Blood. 131(14), 1568-1575.
(2018).
How We Manage Patients with Plasmacytomas..
Curr Hematol Malig Rep. 13(3), 227-235.
(2018).
Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis..
Blood Cancer J. 8(5), 46.
(2018).
The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents..
Blood. 131(4), 464-467.
(2018).
Cardiac and renal complications of carfilzomib in patients with multiple myeloma..
Blood Adv. 1(7), 449-454.
(2017).
Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia..
Leuk Lymphoma. 58(6), 1506-1508.
(2017).
Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma..
Haematologica. 102(3), 593-599.
(2017).
Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens..
Leuk Lymphoma. 58(8), 1832-1839.
(2017).
Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy..
Am J Hematol. 92(7), 632-639.
(2017).
Low circulating mannan-binding lectin levels correlate with increased frequency and severity of febrile episodes in myeloma patients who undergo ASCT and do not receive antibiotic prophylaxis..
Bone Marrow Transplant. 52(11), 1537-1542.
(2017).
Managing renal complications in multiple myeloma..
Expert Rev Hematol. 9(9), 839-50.
(2016).
Evaluation of the cholinergic hypothesis in Alzheimer's disease with neuropsychological methods..
Aging Clin Exp Res. 27(5), 727-33.
(2015).
Pupillometry and 123I-DaTSCAN imaging in Parkinson's disease: a comparison study..
Int J Neurosci. 122(1), 26-34.
(2012).
Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer's disease patients..
Psychiatr Danub. 24(2), 152-8.
(2012).
Pupil light reflex in Parkinson's disease: evaluation with pupillometry..
Int J Neurosci. 121(1), 37-43.
(2011).
Evaluation of autonomic imbalance in patients with heart failure: a preliminary study of pupillomotor function..
Cardiol J. 17(1), 65-72.
(2010).
Morphological changes of the human purkinje cells and deposition of neuritic plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer's disease..
Am J Alzheimers Dis Other Demen. 25(7), 585-91.
(2010).
Pupillometric characteristics in patients with choroidal neovascularization due to age-related macular degeneration..
Eur J Ophthalmol. 19(2), 254-62.
(2009).